Role of dS6 phosphorylation in dTORC1/dS6K mediated longevity in Drosophila

dS6 磷酸化在 dTORC1/dS6K 介导的果蝇寿命中的作用

基本信息

  • 批准号:
    8249374
  • 负责人:
  • 金额:
    $ 21.59万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-04-01 至 2013-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Obesity is a worldwide epidemic that accounts for more than 300,000 deaths per year in the United States alone. Moreover, it is the major reason behind the explosion in health care costs and the disquieting observation that, for the first time in decades, human life span is decreasing for North Americans. A direct consequence of obesity is the enhanced probability of a number of age-related pathologies including diabetes, cardiovascular disease, neurodegenerative disorders, and cancer. The epidemic has been fueled by the availability, abundance, and relatively low cost of food. The critical barrier in controlling the disease has been the inability to overcome dominant human genetic traits that promote the acquisition of food and the storage of energy reserves in the form of adipose depots. It is hypothesized that these traits were selected for during evolution as a consequence of the chronic scarcity of food and that, over time, they have prevailed over those traits that suppress food intake. Given these limitations and the magnitude of the obesity epidemic, it is critical to develop novel intervention strategies, such as targeted drug therapies. The success of such strategies will depend on a basic understanding of the molecular mechanisms that drive these responses. In contrast, to nutritional overload, dietary restriction is a robust environmental manipulation that increases "healthspan", as it not only prolongs life span but also delays the onset of age-related diseases. Although under intense investigation, the underlying molecular mechanisms that lead to obesity-induced pathologies associated with age-related diseases versus those of dietary restriction-induced increases in healthspan have remained difficult to resolve. Nonetheless, one signaling pathway that has emerged as a major player in both responses is that mediated by mTORC1. Under conditions of nutritional overload, this pathway is fully activated and known to contribute to obesity and insulin resistance. In contrast, under conditions of dietary restriction this signaling pathway is suppressed, which has been demonstrated to contribute to increased healthspan. Importantly, conservation of signaling pathways in simpler eukaryotes and the rapidity with which healthspan studies can be carried out make research in model organisms such as Drosophila invaluable in elucidating healthspan-related diseases in humans. Moreover, studies in different organisms have shown that the nutrient arm of the mTORC1 signaling pathway is highly conserved from yeast to man and is a central mediator of the effect of dietary restriction. S6K1 is a well established downstream target of mTORC1 whose deficiency in the mouse has been shown to increase insulin sensitivity, increase resistance to diet-induced obesity, and increase life span, while sparing animals from much age-related pathology. Several downstream substrates of S6K1 have been identified; however, those mediating healthspan are unknown. We propose that phosphorylation of dS6, the first-identified downstream substrate of S6K1, is an essential player in dietary restriction-mediated healthspan extension. We provide preliminary data to support this novel hypothesis. PUBLIC HEALTH RELEVANCE: Obesity, which has recently become a worldwide epidemic, is well recognized for its deleterious effects on health whereas dietary restriction increases healthspan, as it delays the onset of age- related diseases. The mTORC1/S6K1 signaling pathway has emerged as a major player in both states: under conditions of nutritional overload, this pathway contributes to obesity and insulin resistance while under conditions of dietary restriction it is suppressed and increases healthspan. The proposed project will use Drosophila model and analyze a downstream effector of this signaling pathway, the phosphorylation of S6, to reveal the mechanisms by which it affects dietary restriction mediated healthspan extension.
描述(由申请人提供):肥胖是一种世界范围内的流行病,仅在美国每年就造成超过 300,000 人死亡。此外,这是医疗保健费用激增以及令人不安的观察背后的主要原因,即北美人的寿命几十年来首次下降。肥胖的直接后果是增加许多与年龄相关的疾病的可能性,包括糖尿病、心血管疾病、神经退行性疾病和癌症。食品的供应、丰富和相对低廉的成本助长了这一流行病。控制这种疾病的关键障碍是无法克服人类显性遗传特征,这些特征促进食物的获取和以脂肪库形式储存能量储备。据推测,这些特征是在进化过程中由于食物的长期匮乏而被选择的,并且随着时间的推移,它们已经战胜了那些抑制食物摄入的特征。鉴于这些局限性和肥胖流行的严重程度,制定新的干预策略(例如靶向药物疗法)至关重要。此类策略的成功将取决于对驱动这些反应的分子机制的基本了解。相比之下,与营养过剩相比,饮食限制是一种强有力的环境操纵,可以延长“健康寿命”,因为它不仅可以延长寿命,还可以延缓与年龄相关的疾病的发生。尽管正在进行深入的研究,但导致肥胖引起的与年龄相关疾病相关的病理与饮食限制引起的健康寿命增加的潜在分子机制仍然难以解决。尽管如此,在这两种反应中已成为主要参与者的一条信号通路是由 mTORC1 介导的。在营养过剩的情况下,该途径被完全激活,并且已知会导致肥胖和胰岛素抵抗。相反,在饮食限制的情况下,该信号通路受到抑制,这已被证明有助于延长健康寿命。重要的是,简单真核生物中信号通路的保守性以及健康寿命研究的快速进行使得对果蝇等模式生物的研究对于阐明人类与健康寿命相关的疾病具有不可估量的价值。此外,对不同生物体的研究表明,mTORC1 信号通路的营养臂从酵母到人类都是高度保守的,并且是饮食限制效应的核心调节因子。 S6K1 是 mTORC1 的一个成熟的下游靶点,在小鼠中,S6K1 的缺乏已被证明可以增加胰岛素敏感性,增强对饮食引起的肥胖的抵抗力,并延长寿命,同时使动物免受许多与年龄相关的病理影响。 S6K1 的几种下游底物已被鉴定;然而,那些调节健康寿命的因素尚不清楚。我们提出,dS6 的磷酸化(第一个确定的 S6K1 下游底物)在饮食限制介导的健康寿命延长中发挥着重要作用。我们提供初步数据来支持这一新颖的假设。 公共健康相关性:肥胖最近已成为世界范围内的流行病,众所周知,它对健康有害,而饮食限制则可以延长健康寿命,因为它可以延缓与年龄相关的疾病的发生。 mTORC1/S6K1 信号通路已成为这两种状态的主要参与者:在营养过剩的情况下,该通路会导致肥胖和胰岛素抵抗,而在饮食限制的情况下,该通路会受到抑制并延长健康寿命。拟议的项目将使用果蝇模型并分析该信号通路的下游效应器(S6 的磷酸化),以揭示其影响饮食限制介导的健康寿命延长的机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GEORGE THOMAS其他文献

GEORGE THOMAS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GEORGE THOMAS', 18)}}的其他基金

The Function of rpL5 and rpL11 in induction of p53
rpL5和rpL11在p53诱导中的作用
  • 批准号:
    8236578
  • 财政年份:
    2012
  • 资助金额:
    $ 21.59万
  • 项目类别:
The Function of rpL5 and rpL11 in induction of p53
rpL5和rpL11在p53诱导中的作用
  • 批准号:
    8616731
  • 财政年份:
    2012
  • 资助金额:
    $ 21.59万
  • 项目类别:
The Function of rpL5 and rpL11 in induction of p53
rpL5和rpL11在p53诱导中的作用
  • 批准号:
    8434834
  • 财政年份:
    2012
  • 资助金额:
    $ 21.59万
  • 项目类别:
The Function of rpL5 and rpL11 in induction of p53
rpL5和rpL11在p53诱导中的作用
  • 批准号:
    8819106
  • 财政年份:
    2012
  • 资助金额:
    $ 21.59万
  • 项目类别:
Role of dS6 phosphorylation in dTORC1/dS6K mediated longevity in Drosophila
dS6 磷酸化在 dTORC1/dS6K 介导的果蝇寿命中的作用
  • 批准号:
    8103504
  • 财政年份:
    2011
  • 资助金额:
    $ 21.59万
  • 项目类别:
Model systems for hematologic disorders caused by ribosomal protein deficiency
核糖体蛋白缺乏引起的血液疾病模型系统
  • 批准号:
    7828266
  • 财政年份:
    2009
  • 资助金额:
    $ 21.59万
  • 项目类别:
Model systems for hematologic disorders caused by ribosomal protein deficiency
核糖体蛋白缺乏引起的血液疾病模型系统
  • 批准号:
    7828266
  • 财政年份:
    2009
  • 资助金额:
    $ 21.59万
  • 项目类别:
The Effect of Diet and Nutrients on the Progression and Treatment of Prostate Can
饮食和营养素对前列腺疾病进展和治疗的影响
  • 批准号:
    8539746
  • 财政年份:
    2009
  • 资助金额:
    $ 21.59万
  • 项目类别:
The Effect of Diet and Nutrients on the Progression and Treatment of Prostate Can
饮食和营养素对前列腺疾病进展和治疗的影响
  • 批准号:
    7922175
  • 财政年份:
    2009
  • 资助金额:
    $ 21.59万
  • 项目类别:
CRYOEM OF THE DECAMERIC RING FORMED BY THE P22 TERMINASE SMALL SUBUNIT (GP3)
P22 末端酶小亚基 (GP3) 形成的十聚环的冷冻
  • 批准号:
    7956442
  • 财政年份:
    2009
  • 资助金额:
    $ 21.59万
  • 项目类别:

相似国自然基金

FTL+ALB+脂肪干细胞与CD36+EBF2-内皮细胞通过交互作用影响脂肪组织衰老的机制研究
  • 批准号:
    82370884
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
脂肪组织中SIRT3通过抑制外泌体miR-30a-3p调控肝脏自噬影响非酒精性脂肪肝病的机制研究
  • 批准号:
    32360174
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
ANGPTLs基因及其蛋白表达水平调控内脏脂肪组织影响健康衰老表型的前瞻性队列研究
  • 批准号:
    82373661
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
肥胖脂肪组织小囊泡转运鞘磷脂调控鞘磷脂水解代谢促进破骨分化影响骨质疏松的机制研究
  • 批准号:
    32300985
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
HNRNPA1通过转录调控KRAS影响脂肪组织葡萄糖稳态的作用研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Predictors of Youth-Onset Type 2 Diabetes: UAB Clinical Center
青年发病 2 型糖尿病的预测因子:UAB 临床中心
  • 批准号:
    10582927
  • 财政年份:
    2023
  • 资助金额:
    $ 21.59万
  • 项目类别:
Role of the Infrapatellar Fat Pad in the Development of Post-Traumatic Osteoarthritis Following Blunt Impact to the Knee Joint
髌下脂肪垫在膝关节钝性撞击后发生创伤后骨关节炎中的作用
  • 批准号:
    10654180
  • 财政年份:
    2023
  • 资助金额:
    $ 21.59万
  • 项目类别:
Simulation and Education Tool for Physical Examinations of Orthopedic Pathologies
用于骨科病理体检的模拟和教育工具
  • 批准号:
    10484180
  • 财政年份:
    2022
  • 资助金额:
    $ 21.59万
  • 项目类别:
Hyaluronan as a mediator of intrauterine growth restriction-induced islet dysfunction in type 2 diabetes
透明质酸作为 2 型糖尿病宫内生长受限诱导的胰岛功能障碍的介质
  • 批准号:
    10630158
  • 财政年份:
    2021
  • 资助金额:
    $ 21.59万
  • 项目类别:
Hyaluronan as a mediator of intrauterine growth restriction-induced islet dysfunction in type 2 diabetes
透明质酸作为 2 型糖尿病宫内生长受限诱导的胰岛功能障碍的介质
  • 批准号:
    10436997
  • 财政年份:
    2021
  • 资助金额:
    $ 21.59万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了